- Home
- LIVN vs AAUC Comparison
LIVN vs AAUC Comparison
Compare LIVN & AAUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- AAUC
- Stock Information
- Founded
- LIVN 1987
- AAUC N/A
- Country
- LIVN United Kingdom
- AAUC Canada
- Employees
- LIVN N/A
- AAUC N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AAUC
- Sector
- LIVN Health Care
- AAUC
- Exchange
- LIVN Nasdaq
- AAUC Nasdaq
- Market Cap
- LIVN 2.1B
- AAUC 1.7B
- IPO Year
- LIVN 1993
- AAUC N/A
- Fundamental
- Price
- LIVN $46.25
- AAUC $13.83
- Analyst Decision
- LIVN Strong Buy
- AAUC
- Analyst Count
- LIVN 7
- AAUC 0
- Target Price
- LIVN $59.29
- AAUC N/A
- AVG Volume (30 Days)
- LIVN 576.2K
- AAUC 82.9K
- Earning Date
- LIVN 07-30-2025
- AAUC 08-08-2025
- Dividend Yield
- LIVN N/A
- AAUC N/A
- EPS Growth
- LIVN N/A
- AAUC N/A
- EPS
- LIVN N/A
- AAUC N/A
- Revenue
- LIVN $1,275,380,000.00
- AAUC $901,722,000.00
- Revenue This Year
- LIVN $8.10
- AAUC $72.24
- Revenue Next Year
- LIVN $5.76
- AAUC $28.54
- P/E Ratio
- LIVN N/A
- AAUC N/A
- Revenue Growth
- LIVN 7.62
- AAUC 33.30
- 52 Week Low
- LIVN $32.48
- AAUC $13.05
- 52 Week High
- LIVN $57.35
- AAUC $15.79
- Technical
- Relative Strength Index (RSI)
- LIVN 51.18
- AAUC N/A
- Support Level
- LIVN $44.28
- AAUC N/A
- Resistance Level
- LIVN $46.17
- AAUC N/A
- Average True Range (ATR)
- LIVN 1.13
- AAUC 0.00
- MACD
- LIVN -0.27
- AAUC 0.00
- Stochastic Oscillator
- LIVN 22.61
- AAUC 0.00
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.